USO DA IVERMECTINA NA PANDEMIA DE COVID-19: EFICÁCIA, SEGURANÇA E DESAFIOS DA DESINFORMAÇÃO

Abstract

Introduction: Throughout the COVID-19 pandemic, there has been extensive discourse and utilization of Ivermectin, often without discrimination and relying on unsubstantiated information. Objective: This study endeavors to scrutinize the administration of Ivermectin within the COVID-19 framework, assessing its effectiveness, safety, and the challenges posed by associated misinformation. Methodology: Employing electronic databases and stringent inclusion and exclusion criteria, a narrative and integrative review of the literature was conducted. Results and Discussion: Findings disclose a divergence of perspectives regarding the efficacy and safety of Ivermectin, whereby some studies indicate potential advantages alongside noteworthy risks, notably liver toxicity and drug interactions. Moreover, the proliferation of misinformation has fueled a surge in the indiscriminate usage of the drug. Final considerations: Given the revelations, the significance of a prudent stance towards Ivermectin utilization in COVID-19 is underscored, underscoring the imperative for educational initiatives aimed at debunking misinformation and fostering the judicious use of pharmaceuticals.